| __timestamp | Iovance Biotherapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 4101058 |
| Thursday, January 1, 2015 | 15470000 | 10763215 |
| Friday, January 1, 2016 | 28037000 | 5579049 |
| Sunday, January 1, 2017 | 71615000 | 32051299 |
| Monday, January 1, 2018 | 99828000 | 24482286 |
| Tuesday, January 1, 2019 | 166023000 | 43892589 |
| Wednesday, January 1, 2020 | 201727000 | 44505000 |
| Friday, January 1, 2021 | 259039000 | 79406000 |
| Saturday, January 1, 2022 | 294781000 | 49283000 |
| Sunday, January 1, 2023 | 344077000 | 17282730 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Iovance Biotherapeutics, Inc. and Verona Pharma plc have demonstrated contrasting strategies in their R&D investments.
Since 2014, Iovance has consistently increased its R&D spending, culminating in a staggering 12,600% increase by 2023. This aggressive investment strategy underscores Iovance's dedication to advancing its pipeline of cancer immunotherapies.
Conversely, Verona Pharma's R&D spending has been more conservative, peaking in 2021 with a 1,800% increase from 2014. Despite a dip in 2023, Verona's focus remains on respiratory disease treatments.
These divergent paths highlight the varied approaches biotech firms take in their quest for groundbreaking therapies, reflecting their unique market positions and strategic priorities.
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: PTC Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.